Literature DB >> 7729940

Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study.

A O Olsen1, K Gjøen, T Sauer, I Orstavik, O Naess, K Kierulf, G Sponland, P Magnus.   

Abstract

The association between certain human papillomaviruses (HPV) and cervical intraepithelial neoplasia (CIN) is well documented, but there is uncertainty about the strength of association and the role of co-factors is unclear. This population-based case-control study in Norwegian women 20-44 years of age included 103 cases with histologically confirmed CIN II-III and 234 age-matched and randomly selected controls. Cytological specimens from the cervix were analyzed using the polymerase chain reaction (PCR). In all, 91% of the cases and 15% of the controls were HPV DNA positive, giving a crude odds ratio (OR) of 67.2 (95% confidence interval: 28.6-157.5). The association between HPV 16 and CIN II-III was even stronger (crude OR = 123.9; 46.7 - 328.5). In logistic regression analysis, additional to HPV, only a high number of sexual partners and a low educational level contributed independently to the risk. The adjusted OR for the association between HPV and CIN II-III was 72.8 (95% CI: 27.6-191.9). The association between HPV and CIN remains very strong even after adjustment for proposed confounding factors. The results therefore support the role of HPV as a causative agent in the development of CIN.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729940     DOI: 10.1002/ijc.2910610306

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

Authors:  N R Chu; H B Wu; T Wu; L J Boux; M I Siegel; L A Mizzen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA.

Authors:  A O Olsen; J Dillner; K Gjøen; P Magnus
Journal:  Genitourin Med       Date:  1997-04

4.  Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7.

Authors:  N R Chu; H B Wu; T C Wu; L J Boux; L A Mizzen; M I Siegel
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

5.  Identification and characterization of novel mutations in the human gene encoding the catalytic subunit Calpha of protein kinase A (PKA).

Authors:  Kristoffer Søberg; Anja C V Larsen; Mandy Diskar; Paul H Backe; Magnar Bjørås; Tore Jahnsen; Jon K Laerdahl; Torbjørn Rognes; Friedrich W Herberg; Bjørn S Skålhegg
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 6.  A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions.

Authors:  J Cuzick; P Sasieni; P Davies; J Adams; C Normand; A Frater; M van Ballegooijen; E van den Akker-van Marle
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

7.  Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan.

Authors:  H Yoshikawa; C Nagata; K Noda; S Nozawa; A Yajima; S Sekiya; H Sugimori; Y Hirai; K Kanazawa; M Sugase; H Shimizu; T Kawana
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Cancer of the Uterine Cervix.

Authors:  Eliane Duarte-Franco; Eduardo L Franco
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

9.  Human papillomavirus (HPV) infection and intraepithelial neoplasia and invasive cancer of the uterine cervix: a case-control study in Zaragoza, Spain.

Authors:  Milagros Bernal; Isabel Burillo; Jose I Mayordomo; Manuel Moros; Rafael Benito; Joaquina Gil
Journal:  Infect Agent Cancer       Date:  2008-05-29       Impact factor: 2.965

10.  Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies.

Authors:  K Matsumoto; T Yasugi; A Oki; H Hoshiai; Y Taketani; T Kawana; H Yoshikawa
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.